Supplementary Table S1 . Summary of cell lines used.

Oct 23, 2014

20 likes | 166 Views

Share Presentation

Embed Code

Link

summary
cell lines
supplementary table s1

inoke

Download Presentation

Supplementary Table S1 . Summary of cell lines used.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary Table S1. Summary of cell lines used.

Supplementary Figure S1

Supplementary Figure S1. A. concentration in cell, m M. Cmpd 1. Cmpd 2. Cmpd 3. B. NADH. Cmpd IC50. 120 m M. 67 nM. 100. 60 m M. 43 nM. 30 m M. 22 nM. 75. 5 m M. 12 nM. % inhibition. 50. 25. -9. -8. -7. -6. -5. Compound 2. Supplementary Figure S2. A. 13 C.

192 views • 8 slides

Supplementary Table S1. List of oligonucleotide primers used for amplification

Supplementary Table S1. List of oligonucleotide primers used for amplification of RSV RNA1 and RNA2 segments. Supplementary Table S2. GenBank accession numbers of RSV RNA 1 and RNA2 segments used in the study. Jonson et al. Supplementary Fig. S1. (A) RNA2 ORF1. (B) RNA2 ORF2. BA2-JB.

228 views • 3 slides

Supplementary Figure S1

Supplementary Figure S1. A. B. C. D. E.

77 views • 1 slides

Yu et al, Supplementary Table S1 (continued)

Supplementary Fig. S1. Comparison of conserved eight RdRp motifs of FgV3 and FgV4 with the other dsRNA mycoviruses using amino acid sequences. Numbers I-VIII indicate the eight conserved motifs in RdRps of dsRNA viruses of lower eukaryotes. Ⅰ. Ⅱ. Ⅲ. Yu et al, Supplementary Table S1 (continued).

114 views • 2 slides

Supplementary Fig. S1.

Supplementary Fig. S1. Supplementary Fig. S2. Supplementary Fig. S3. Supplementary Fig. S4.

117 views • 4 slides

Table S1. Mutational status of pancreatic cell lines used.

87 views • 1 slides

Supplementary Figure S1

Supplementary Figure S1. kDa. 70. 55. FLAG monomer. 40. 35. 25. Supplementary Figure S2. kDa. 250. 130. 100. 70. 55. Supplementary Figure S3.

152 views • 3 slides

Summary Testing New Cell Lines

Summary Testing New Cell Lines. Currently underway: exploration of 7 cell lines (J774A.1, Raw 264.7, AtT-20, 3T3-L1, IC21, Neuro 2a, N1E-115) “A” list: J774A.1, Raw 264.7, AtT-20 Rich responses (inputs and outputs) Ectopic expression of proteins

176 views • 6 slides

Shiono M, et al. Supplementary Table S1

Shiono M, et al. Supplementary Table S1. Shiono M, et al. Supplementary Table S2. B. C. DAPI. WT. a. b. DAPI. WT. DAPI. NSM. DAPI. NSM. merge. Tsc1. merge. merge. Tsc1. merge. c. D. DAPI. DAPI. GSM. GSM. d. DAPI. merge. Tsc1. merge. Tsc1. f. e. DAPI. NSM. DAPI.

142 views • 6 slides

Supplementary Fig. S1

Supplementary Fig. S1. Individual Animal Data for Methylation- Sensitive Restriction Digestion, followed by Arbitrarily-Primed PCR (AP-PCR) and Capillary Eletrophoresis, for B6C3F1 and C57BL/6 Mice, 2 and 4 Week Control and 0.05% (w/w) PB Treatment Groups.

348 views • 25 slides

Supplementary Figure S1

Supplementary Figure S1. Clinical data collection, N = 336. (diagnosed by each hospital). Excluded, n = 29 (9%) Pathological sample not available. Central review of pathology, n = 307. Excluded, n = 76 (25%) 17 Malignant lymphoma, not otherwise specified

104 views • 3 slides

Supplementary Table S1

Relationship between the miRNA-21 in plasma and primary ESCC tissues. Supplementary Table S1. Relationship between the miRNA-375 in plasma and primary ESCC tissues. Supplementary Table S2. 1.0. 1.0. 0.8. 0.8. 0.6. 0.6. 0.4. 0.4. 0.2. 0.2. miR-21 AUC=0.618. miR-375 AUC=0.807. 0. 0.

88 views • 3 slides

Supplementary Fig. S1

C. 200. 160. r 2 = 0.1975 P = 0.0028. 120. Relative SMYD2 protein expression (Arbitrary unit determined by densitometer). 80. 40. 0. 0. 1. 2. 3. 4. 5. 6. Relative SMYD2 mRNA expression (/ normal esophagus). Supplementary Fig. S1. A. CENPF mRNA. 8. 6.

102 views • 1 slides

Supplementary Table S1.

Supplementary Table S1. Primer sequences used for PCR amplification of DDAH1, DDAH2 and tubulin message. Supplementary Figures. s1A. s1B. s1C. s1D.

221 views • 6 slides

Supplementary Table S1

Supplementary Table S1.

66 views • 1 slides

Supplementary Figure S1

Supplementary Figure S1. A. B. Supplementary Figure S2. Supplementary Figure S3. Supplementary Figure S4. Supplementary Figure S5. A. B. C. D. Supplementary Figure S6. A. B. LRP1B relative expression ratio. Supplementary Table S3.

260 views • 8 slides

Supplementary Fig. S1

Supplementary Fig. S1. A. B. SAS-S. SAS cisPt R. SAS-S. SAS cisPt R. G 2. G 1. Glut3(%). Glut3(%). Glut3(%). Glut3(%). G 2. G 1. G 1. G 2. G 4. G 3. CD133(%). CD133(%). mem Grp78(%). mem Grp78(%). G 1. G 2. SAS cisPt R. SAS-S. SAS cisPt R. SAS-S. G1 :

219 views • 11 slides

Supplementary Table S1

Supplementary Table S1. Clinicopathological features of 3 GC patients analysed on miRNA microarray.

105 views • 1 slides

Supplementary Figure S1.

Supplementary Figure S1. 1 H- 15 N HSQC spectra of 15 N-labeled ZG16p titrated with Man- O - Thr (a), Man- O -peptide (b), Manα1-3Man (c) and Glc  1-3Glc (d). Marked peaks are selected for the calculation of dissociation constants (Figure 4). (a) Man- O -Thr. (b) Mannose- O -peptide.

116 views • 2 slides

Supplementary Figure S1

Supplementary Figure S1 Change of reporter activity levels after actinomycin D treatment. HEK293T cells were transiently transfected with the reporter and incubated with actinomycin D for the indicated times.

47 views • 4 slides

More Related